Filgrastim in the Treatment of Infected Diabetic Foot Ulcers: Retrospective Cost Analysis of a Phase II Randomised Clinical Trial

Author： Edmonds M.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.17, Iss.4, 1999-04, pp. : 275-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimal Treatment of Infected Diabetic Foot Ulcers

By Edward B. Jude   Philip F. Unsworth  

Drugs & Aging, Vol. 21, Iss. 13, 2004-01 ,pp. : 833-850

Adis International

Access to resources Recommend Favorite

The Cost Effectiveness of Apligraf ® Treatment of Diabetic Foot Ulcers

By Redekop W.K.  

PharmacoEconomics, Vol. 21, Iss. 16, 2003-01 ,pp. : 1171-1183

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries

By Ghatnekar O.   Persson U.   Willis M.   Odegaard K.  

PharmacoEconomics, Vol. 19, Iss. 7, 2001-07 ,pp. : 767-778

Adis International

Access to resources Recommend Favorite

Diabetic Foot Ulcers: Practical Treatment Recommendations

By Edmonds Michael  

Drugs, Vol. 66, Iss. 7, 2006-01 ,pp. : 913-929

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Becaplermin in the Treatment of Diabetic Foot Ulcers

By Papanas Nikolaos   Maltezos Efstratios  

Drug Safety, Vol. 33, Iss. 6, 2010-06 ,pp. : 455-461

Adis International

Access to resources Recommend Favorite